Immune-related genes to predict clinical outcome of cetuximab (cet) treatment for metastatic colorectal cancer (mCRC): Immuno-Oncology assay research
Sunakawa, Y., et al. Immune-related genes to predict clinical outcome of cetuximab (cet) treatment for metastatic colorectal cancer (mCRC): Immuno-Oncology assay research. J Clin Oncol. 2016;34(Suppl):abstr 11591.
- Categories
- Abstracts